Article Details

Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides ...

Retrieved on: 2024-08-05 20:06:11

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides .... View article details on hiswai:

Excerpt

While Viatris records the total net sales of YUPELRI within its financial statements, Theravance Biopharma's implied 35% share of net sales of YUPELRI ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up